Report from the ESMO Conference on Sarcoma and GIST, 9–10 March 2012, Milan, Italy
Journal Title: OncoReview - Year 2012, Vol 2, Issue 2
Abstract
In 9–10 March 2012, Milan (Italy), the conference organized by the European Society for Medical Oncology (ESMO) took place. The main topic of the conference was sarcomas and gastrointestinal stromal tumors (GIST). This conference has been organized since 2008 and currently there were more than three hundred attendees interested in the field of sarcomas. Among the invited speakers there were world leaders in oncology, surgery, radiotherapy, pathology, molecular biology and radiology, dealing with issues related to sarcomas and GIST. The most important topic of this conference were the histological and molecular aspects of soft tissue sarcomas and GIST, clinical management and current recommendations. It was stressed, the increasing clinical need for a multidisciplinary approach for the treatment of soft tissue sarcomas and GIST, and the important role of clinical trials and transitional research. This report presents the highlights from the meeting.
Authors and Affiliations
Iwona Ługowska, Wirginiusz Dziewirski, Piotr Rutkowski
Keywords
Related Articles
- EP ID EP53153
- DOI -
- Views 213
- Downloads 0
Pheochromocytoma and paraganglioma – an overview
Pheochromocytoma and paraganglioma derive from chromaffin tissue that secretes catecholamines, which determine the characteristic clinical picture of the disease. Serious and potentially fatal cardiovascular complication...
Przydatność kliniczna pomiaru liczby krążących komórek nowotworowych u chorych na raka piersi
Wstęp: Monitorowanie raka piersi po leczeniu adiuwantowym w szczególnych przypadkach może się opierać na zastosowaniu metod obrazowych lub wykonaniu biopsji. W świetle obecnych badań należy zadać pytanie, czy alternatywn...
Advanced skin melanoma – systemic treatment
In Poland, morbidity and mortality rates for melanoma are constantly increasing. In the case of inoperable disease or distant metastases, prognosis remains poor. For many years, dacarbazine has been the gold standard in...
Angioplastyka wieńcowa oraz wymiana zastawki aortalnej u dwóch chorych ze szpiczakiem mnogim - opisy przypadków
Szpiczak mnogi jest schorzeniem hematologicznym charakteryzującym się klonalnym rozrostem atypowych plazmocytów, produkujących monoklonalną immunoglobulinę. Roczna zapadalność na niego w Europie wynosi ok. 4,5/100 000 os...
A role of JAK in the pathogenesis of Philadelphia negative myeloproliferative neoplasms. Target therapy possibilities
In recent years a significant progress has been made in understanding of the pathogenesis of myeloproliferative neoplasms, especially the one with mutation in JAK2 gene. In 2005 several study groups confirmed the presenc...